Compare KNTK & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KNTK | SUPN |
|---|---|---|
| Founded | 2017 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 3.0B |
| IPO Year | 2017 | 2010 |
| Metric | KNTK | SUPN |
|---|---|---|
| Price | $47.32 | $51.54 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 5 |
| Target Price | $48.58 | ★ $61.60 |
| AVG Volume (30 Days) | ★ 1.0M | 601.1K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | ★ 6.53% | N/A |
| EPS Growth | ★ 157.84 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $160,617,000.00 | ★ $392,755,000.00 |
| Revenue This Year | $7.80 | $22.70 |
| Revenue Next Year | $13.93 | $19.14 |
| P/E Ratio | $18.37 | ★ N/A |
| Revenue Growth | ★ 8.23 | N/A |
| 52 Week Low | $31.33 | $31.16 |
| 52 Week High | $51.11 | $59.68 |
| Indicator | KNTK | SUPN |
|---|---|---|
| Relative Strength Index (RSI) | 46.63 | 57.17 |
| Support Level | $44.07 | $47.85 |
| Resistance Level | $48.37 | $52.26 |
| Average True Range (ATR) | 1.45 | 2.09 |
| MACD | -0.15 | 0.34 |
| Stochastic Oscillator | 27.39 | 77.34 |
Kinetik Holdings Inc is a midstream operator that provides comprehensive gathering, transportation, compression, processing and treating services. Its activities also include NGL stabilization and transportation, produced water gathering and disposal, and crude oil gathering, stabilization, storage, and transportation. The company operates in two reportable segments: i) The Midstream Logistics segment operates under three service offerings: 1) gas gathering and processing, 2) crude oil gathering, stabilization, and storage services, and 3) produced water gathering and disposal. ii) The Pipeline Transportation segment consists of two EMI Pipelines originating in the Permian Basin with various access points to the U.S. Gulf Coast, Kinetik NGL Pipelines, and Delaware Link Pipeline.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.